Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee Osteoarthritis

• Status: Completed
• Trial end date: 2018-04-28
• Target enrollment: 0
• Participant gender: All

Summary

the study was conducted on 31-patients with symptomatic primary knee osteoarthritis. The patients were randomized into intervention and control groups. The control group was kept on their medications without intervention. The intervention group received two doses of allogenic lyophilized growth factors (L-GFs); at baseline and after 2 months.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rasmia Elgohary
• Treatments: Mitogens

Criteria

Inclusion Criteria

• Clinical and radiographic diagnosis of primary knee osteoarthritis

• Patients must be symptomatic

Exclusion Criteria:

• Patients with secondary knee osteoarthritis

• previous intra-articular steroid, or hyaluronic knee injection in last year

• Patients with other disabling lower limb osteoarthropathy or myopathy